Synergistic herb pairings of traditional Chinese medicine: applications and advances in the treatment of Parkinson's disease

Roujia Xie

doi:10.54254/3029-0821/2025.26711

Article Information

Received: 4 September 2025

Published: 15 September 2025

DOI: https://doi.org/10.54254/3029-0821/2025.26711

Article Type: Research Article

Cite this article

Xie,R. (2025). Synergistic herb pairings of traditional Chinese medicine: applications and advances in the treatment of Parkinson's disease. Journal of Food Science, Nutrition and Health,4(2),1-5.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About this Volume

Volume Title: JFSNH Vol.4

Part of Series: Journal of Food Science, Nutrition and Health

ISSN: 3029-0821 (Print) / 3029-083X (Online)

Copyright & License

[1]Qi, S., Yin, P., Wang, L., Qu, M., Kan, G. L., Zhang, H., Zhang, Q., Xiao, Y., Deng, Y., Dong, Z., Shi, Y., Meng, J., Chan, P., & Wang, Z. (2021). Prevalence of Parkinson's disease: A community-based study in China.Movement Disorders, 36(12), 2940–2944.

[2]Tan, C., Chen, Z. G., & Chen, L. (2022). Research progress on the mechanisms of levodopa-induced dyskinesia in Parkinson's disease.Chinese Journal of Neuroimmunology and Neurology, 29(3), 256–260.

[3]Wu, M. Z., & Zhang, L. G. (2020). Investigation of the efficacy of Madopar combined with pramipexole in the treatment of Parkinson's disease and its impact on quality of life.China Practical Medicine, 15(2), 153–155.

[4]Wang, J. K., Li, T., Liu, A. J., et al. (2025). Exploring medication patterns of traditional Chinese medicine for non-motor symptoms of Parkinson's disease based on data mining.Journal of Practical Traditional Chinese Internal Medicine, 39(6), 61–65, 151–152.

[5]Wang, Y. Y., Jiang, D. S., Hou, L. N., et al. (1986). Clinical observation on the efficacy of traditional Chinese medicine in 35 cases of paralysis agitans (Parkinson's syndrome).Journal of Traditional Chinese Medicine, 8, 22–24.

[6]He, J. C., & Wang, W. W. (2010). Effect of Tianma Gouteng Yin on apoptosis of dopaminergic neurons in Parkinson's disease model rats.Journal of Traditional Chinese Medicine, 11, 1024–1027.

[7]Yu, X. L., Luo, Y., Yang, L. P., et al. (2023). Effect and mechanism of p-hydroxybenzyl alcohol on cerebral ischemia-reperfusion injury by SIRT1/PGC-1α/TFAM signaling pathway.Chinese Journal of Hospital Pharmacy, 43(1), 42–47.

[8]Wang, X. M., & Lu, X. S. (2014). The regulation of rhynchophylline on the expression levels of dopamine, superoxide dismutase and malondialdehyde in rats with Parkinson disease.Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 12(6), 730–731.

[9]Zhao, B. B., Hu, T., Lin, B. X., et al. (2024). Study on the neuroprotective mechanisms of Shaoyao Gancao decoction on nigral dopaminergic neurons in a rat model of Parkinson's disease.Journal of Li-Shizhen Traditional Chinese Medicine, 35(13), 2986–2992.

[10]Chen, K. Y., Gao, Z. Z., Yang, Y. Y., et al. (2022). Academician Tong Xiaolin's experience in differentiating and treating marrow system diseases in Dingjiao.Journal of Changchun University of Chinese Medicine, 38(2), 119–122.

[11]Yao, S. Y. (2017). Expression and significance of brain derived neurotrophic factor and stromal cell derived factor 1 in the hippocampus of rats with cerebral ischemia reperfusion.Journal of Navy Medicine, 38(3), 219–221.

[12]Huang, Q., Zeng, L., & Wang, G. X., et al. (2022). Research progress in the traditional Chinese medicine treatment of insomnia by adjusting intestinal flora based on microbiota-gut-brain axis theory.Tianjin Journal of Traditional Chinese Medicine, 39(4), 538–544.

[13]Xu, Y. D. (2018). Neuroprotective effects of loganin on MPTP-induced Parkinson's disease mouse model (Master’s thesis).Jiangnan University.